AD is often characterised by amyloid-β (Aβ) and tau dysfunction; however, progressive synaptic loss and neurite degeneration, alongside changes to mitochondrial function, oxidative stress, and proteostasis, are also associated with disease progression [2]. This evidence concerns the gene MAPT and Alzheimer disease.